Foghorn Therapeutics Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent
Foghorn Therapeutics Inc. (FHTX) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent of -3.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch · last filed 2026-03-11
- Foghorn Therapeutics Inc. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2025 was -3.00%.
- Foghorn Therapeutics Inc. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2024 was -4.90%.
- Foghorn Therapeutics Inc. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2023 was -5.50%.
- Foghorn Therapeutics Inc. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2022 was -4.30%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -3.00% 10-K · filed 2026-03-11 | |
| 2024-12-31 | -4.90% 10-K · filed 2026-03-11 | |
| 2023-12-31 | -5.50% 10-K · filed 2025-03-06 | |
| 2022-12-31 | -4.30% 10-K · filed 2024-03-07 | |
| 2021-12-31 | -4.40% 10-K · filed 2023-03-09 | 4.40% 10-K · filed 2022-03-10 |
| 2020-12-31 | 3.70% 10-K/A · filed 2022-08-09 | -3.70% 10-K · filed 2021-03-18 |
| 2019-12-31 | -2.20% 10-K · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |